27-01-2025
Plantocol Launches Brand and Patent-Pending ATV Protocol for Lupus SLE Symptom Support
Miami, FL - January 27, 2025 - Plantocol, a forward-thinking supplement company, has officially launched its — brand, unveiling the innovative patent-pending ATV (Autotheravive) protocol aimed at supporting individuals managing the symptoms of Lupus SLE (Systemic Lupus Erythematosus). Pre-orders for this breakthrough supplement system are now available via the company's website,
The ATV Protocol is a targeted, science-based approach that combines four carefully selected ingredients to address common concerns associated with Lupus SLE, such as fatigue, inflammation, and musculoskeletal discomfort. Designed to work synergistically, the protocol represents a fresh perspective on symptom management, using natural ingredients backed by emerging research.
The ATV Protocol includes:
Vitamin D3 + K2: Studies from the National Institutes of Health (NIH) indicate that Vitamin D3 can play a crucial role in immune system regulation, while Vitamin K2 supports bone health and helps mitigate inflammation—two prevalent concerns for those living with Lupus SLE.
Magnesium Complex: Research published in the Journal of Magnesium Research highlights magnesium's benefits in improving energy levels, reducing muscle pain, and alleviating stress, which are common challenges for Lupus patients.
Trans-Resveratrol 99% Standardized: Peer-reviewed studies from Oxidative Medicine and Cellular Longevity emphasize the antioxidant and anti-inflammatory properties of Trans-Resveratrol, offering relief from oxidative stress and chronic inflammation.
Solanum Dulcamara (Bittersweet Nightshade) Root Extract: Preliminary findings in the Journal of Ethnopharmacology suggest its immunomodulatory effects may help manage joint pain and skin-related symptoms associated with autoimmune conditions.
'Our goal with Plantocol is to empower those living with Lupus SLE by providing a solution rooted in research, innovation, and natural synergy,' said Keven Pimentel, Founder of Plantocol. 'This patent-pending protocol reflects our commitment to advancing natural health while addressing the unique needs of the autoimmune community.'
What distinguishes Plantocol's ATV Protocol is its focus on synergy — ensuring that each component enhances the effectiveness of the others when taken as a complete system. By harnessing this approach, the company aims to provide Lupus SLE patients with a holistic option for symptom support.
The patent application for the ATV Protocol is currently filed with the U.S. Patent Office, underscoring Plantocol's dedication to delivering scientifically-driven, proprietary solutions to the health and wellness market.
Pre-orders are open now, with the first shipment scheduled for June 2025. For more details or to reserve your order, visit
Media Contact
Company Name: Plantocol
Contact Person: Keven Pimentel
Email: Send Email
Country: United States
Website: